Clinical Trial Update: Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

View source ↗

Summary

This recruiting study from the National Human Genome Research Institute aims to understand whether genetic factors influence the risk of developing an immune re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Sickle Cell Disease | Status: RECRUITING